Global Human Serum Albumin Fusion Protein Drug Market Growth (Status and Outlook) 2026-2032

April 2026 | 79 pages | ID: G2FE5D93533CEN
LP Information

Abstracts

The global Human Serum Albumin Fusion Protein Drug market size is predicted to grow from US$ 1132 million in 2025 to US$ 2584 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032.

Fusion proteins have been well-studied and widely applied in biopharmaceutics. Albumin fusion proteins are simple to construct, easy to purify, and stable to formulate.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the ?Human Serum Albumin Fusion Protein Drug Industry Forecast? looks at past sales and reviews total world Human Serum Albumin Fusion Protein Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Serum Albumin Fusion Protein Drug sales for 2026 through 2032. With Human Serum Albumin Fusion Protein Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Serum Albumin Fusion Protein Drug industry.

This Insight Report provides a comprehensive analysis of the global Human Serum Albumin Fusion Protein Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Serum Albumin Fusion Protein Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Serum Albumin Fusion Protein Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Serum Albumin Fusion Protein Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Serum Albumin Fusion Protein Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Serum Albumin Fusion Protein Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Idelvion
• Tanzeum

Segmentation by Application:

• Hemophilia
• Diabetes
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GSK
• CSL Behring

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Serum Albumin Fusion Protein Drug Market Size (2021-2032)
  2.1.2 Human Serum Albumin Fusion Protein Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Human Serum Albumin Fusion Protein Drug by Country/Region (2021, 2025 & 2032)
2.2 Human Serum Albumin Fusion Protein Drug Segment by Type
  2.2.1 Idelvion
  2.2.2 Tanzeum
  2.2.3 Human Serum Albumin Fusion Protein Drug Market Size by Type
    2.2.3.1 Human Serum Albumin Fusion Protein Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Type (2021-2026)
2.3 Human Serum Albumin Fusion Protein Drug Segment by Application
  2.3.1 Hemophilia
  2.3.2 Diabetes
  2.3.3 Other
  2.3.4 Human Serum Albumin Fusion Protein Drug Market Size by Application
    2.3.4.1 Human Serum Albumin Fusion Protein Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Application (2021-2026)

3 HUMAN SERUM ALBUMIN FUSION PROTEIN DRUG MARKET SIZE BY PLAYER

3.1 Human Serum Albumin Fusion Protein Drug Market Size Market Share by Player
  3.1.1 Global Human Serum Albumin Fusion Protein Drug Revenue by Player (2021-2026)
  3.1.2 Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Player (2021-2026)
3.2 Global Human Serum Albumin Fusion Protein Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUMAN SERUM ALBUMIN FUSION PROTEIN DRUG BY REGION

4.1 Human Serum Albumin Fusion Protein Drug Market Size by Region (2021-2026)
4.2 Global Human Serum Albumin Fusion Protein Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Serum Albumin Fusion Protein Drug Market Size Growth (2021-2026)
4.4 APAC Human Serum Albumin Fusion Protein Drug Market Size Growth (2021-2026)
4.5 Europe Human Serum Albumin Fusion Protein Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Human Serum Albumin Fusion Protein Drug Market Size by Country (2021-2026)
5.2 Americas Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026)
5.3 Americas Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Serum Albumin Fusion Protein Drug Market Size by Region (2021-2026)
6.2 APAC Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026)
6.3 APAC Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Human Serum Albumin Fusion Protein Drug Market Size by Country (2021-2026)
7.2 Europe Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026)
7.3 Europe Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Serum Albumin Fusion Protein Drug by Region (2021-2026)
8.2 Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUMAN SERUM ALBUMIN FUSION PROTEIN DRUG MARKET FORECAST

10.1 Global Human Serum Albumin Fusion Protein Drug Forecast by Region (2027-2032)
  10.1.1 Global Human Serum Albumin Fusion Protein Drug Forecast by Region (2027-2032)
  10.1.2 Americas Human Serum Albumin Fusion Protein Drug Forecast
  10.1.3 APAC Human Serum Albumin Fusion Protein Drug Forecast
  10.1.4 Europe Human Serum Albumin Fusion Protein Drug Forecast
  10.1.5 Middle East & Africa Human Serum Albumin Fusion Protein Drug Forecast
10.2 Americas Human Serum Albumin Fusion Protein Drug Forecast by Country (2027-2032)
  10.2.1 United States Market Human Serum Albumin Fusion Protein Drug Forecast
  10.2.2 Canada Market Human Serum Albumin Fusion Protein Drug Forecast
  10.2.3 Mexico Market Human Serum Albumin Fusion Protein Drug Forecast
  10.2.4 Brazil Market Human Serum Albumin Fusion Protein Drug Forecast
10.3 APAC Human Serum Albumin Fusion Protein Drug Forecast by Region (2027-2032)
  10.3.1 China Human Serum Albumin Fusion Protein Drug Market Forecast
  10.3.2 Japan Market Human Serum Albumin Fusion Protein Drug Forecast
  10.3.3 Korea Market Human Serum Albumin Fusion Protein Drug Forecast
  10.3.4 Southeast Asia Market Human Serum Albumin Fusion Protein Drug Forecast
  10.3.5 India Market Human Serum Albumin Fusion Protein Drug Forecast
  10.3.6 Australia Market Human Serum Albumin Fusion Protein Drug Forecast
10.4 Europe Human Serum Albumin Fusion Protein Drug Forecast by Country (2027-2032)
  10.4.1 Germany Market Human Serum Albumin Fusion Protein Drug Forecast
  10.4.2 France Market Human Serum Albumin Fusion Protein Drug Forecast
  10.4.3 UK Market Human Serum Albumin Fusion Protein Drug Forecast
  10.4.4 Italy Market Human Serum Albumin Fusion Protein Drug Forecast
  10.4.5 Russia Market Human Serum Albumin Fusion Protein Drug Forecast
10.5 Middle East & Africa Human Serum Albumin Fusion Protein Drug Forecast by Region (2027-2032)
  10.5.1 Egypt Market Human Serum Albumin Fusion Protein Drug Forecast
  10.5.2 South Africa Market Human Serum Albumin Fusion Protein Drug Forecast
  10.5.3 Israel Market Human Serum Albumin Fusion Protein Drug Forecast
  10.5.4 Turkey Market Human Serum Albumin Fusion Protein Drug Forecast
10.6 Global Human Serum Albumin Fusion Protein Drug Forecast by Type (2027-2032)
10.7 Global Human Serum Albumin Fusion Protein Drug Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Human Serum Albumin Fusion Protein Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 GSK
  11.1.1 GSK Company Information
  11.1.2 GSK Human Serum Albumin Fusion Protein Drug Product Offered
  11.1.3 GSK Human Serum Albumin Fusion Protein Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 GSK Main Business Overview
  11.1.5 GSK Latest Developments
11.2 CSL Behring
  11.2.1 CSL Behring Company Information
  11.2.2 CSL Behring Human Serum Albumin Fusion Protein Drug Product Offered
  11.2.3 CSL Behring Human Serum Albumin Fusion Protein Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 CSL Behring Main Business Overview
  11.2.5 CSL Behring Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Human Serum Albumin Fusion Protein Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Serum Albumin Fusion Protein Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Idelvion
Table 4. Major Players of Tanzeum
Table 5. Human Serum Albumin Fusion Protein Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Type (2021-2026)
Table 8. Human Serum Albumin Fusion Protein Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Application (2021-2026)
Table 11. Global Human Serum Albumin Fusion Protein Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Player (2021-2026)
Table 13. Human Serum Albumin Fusion Protein Drug Key Players Head office and Products Offered
Table 14. Human Serum Albumin Fusion Protein Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Human Serum Albumin Fusion Protein Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Region (2021-2026)
Table 19. Global Human Serum Albumin Fusion Protein Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Human Serum Albumin Fusion Protein Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Human Serum Albumin Fusion Protein Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Human Serum Albumin Fusion Protein Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Human Serum Albumin Fusion Protein Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC Human Serum Albumin Fusion Protein Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Human Serum Albumin Fusion Protein Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Human Serum Albumin Fusion Protein Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Human Serum Albumin Fusion Protein Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Human Serum Albumin Fusion Protein Drug
Table 39. Key Market Challenges & Risks of Human Serum Albumin Fusion Protein Drug
Table 40. Key Industry Trends of Human Serum Albumin Fusion Protein Drug
Table 41. Global Human Serum Albumin Fusion Protein Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Human Serum Albumin Fusion Protein Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Human Serum Albumin Fusion Protein Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. GSK Details, Company Type, Human Serum Albumin Fusion Protein Drug Area Served and Its Competitors
Table 46. GSK Human Serum Albumin Fusion Protein Drug Product Offered
Table 47. GSK Human Serum Albumin Fusion Protein Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. GSK Main Business
Table 49. GSK Latest Developments
Table 50. CSL Behring Details, Company Type, Human Serum Albumin Fusion Protein Drug Area Served and Its Competitors
Table 51. CSL Behring Human Serum Albumin Fusion Protein Drug Product Offered
Table 52. CSL Behring Human Serum Albumin Fusion Protein Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. CSL Behring Main Business
Table 54. CSL Behring Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Human Serum Albumin Fusion Protein Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Serum Albumin Fusion Protein Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Serum Albumin Fusion Protein Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Serum Albumin Fusion Protein Drug Sales Market Share by Country/Region (2025)
Figure 8. Human Serum Albumin Fusion Protein Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Type in 2025
Figure 10. Human Serum Albumin Fusion Protein Drug in Hemophilia
Figure 11. Global Human Serum Albumin Fusion Protein Drug Market: Hemophilia (2021-2026) & ($ millions)
Figure 12. Human Serum Albumin Fusion Protein Drug in Diabetes
Figure 13. Global Human Serum Albumin Fusion Protein Drug Market: Diabetes (2021-2026) & ($ millions)
Figure 14. Human Serum Albumin Fusion Protein Drug in Other
Figure 15. Global Human Serum Albumin Fusion Protein Drug Market: Other (2021-2026) & ($ millions)
Figure 16. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Application in 2025
Figure 17. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Player in 2025
Figure 18. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Human Serum Albumin Fusion Protein Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Human Serum Albumin Fusion Protein Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Human Serum Albumin Fusion Protein Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Human Serum Albumin Fusion Protein Drug Value Market Share by Country in 2025
Figure 24. United States Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Human Serum Albumin Fusion Protein Drug Market Size Market Share by Region in 2025
Figure 29. APAC Human Serum Albumin Fusion Protein Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Human Serum Albumin Fusion Protein Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Human Serum Albumin Fusion Protein Drug Market Size Market Share by Country in 2025
Figure 38. Europe Human Serum Albumin Fusion Protein Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Human Serum Albumin Fusion Protein Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Human Serum Albumin Fusion Protein Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 61. China Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 65. India Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 68. France Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Human Serum Albumin Fusion Protein Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Human Serum Albumin Fusion Protein Drug Market Size 2027-2032 ($ millions)